a public good project by the
Synthesis
Company
of California

© 2026

Ru Zhou | doi.page

0 works0 citations0 h-index

Ru Zhou

University of British Columbia(CA)

Publications by Year

Research Areas

CAR-T cell therapy research, Immune Cell Function and Interaction, Viral Infections and Immunology Research, Immunotherapy and Immune Responses, Synthesis and Biological Evaluation

Most-Cited Works

→ Calcitriol Suppresses Antiretinal Autoimmunity through Inhibitory Effects on the Th17 Effector Response(2009)345 cited
→ Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes(1999)316 cited
→ Ocular immune privilege(2010)249 cited
→ In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease(1999)223 cited
→ Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P₁ Lactam Moieties as l-Glutamine Replacements(1999)189 cited
→ CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth(2019)181 cited

→ A ∼6Ma chemical weathering history, the grain size dependence of chemical weathering intensity, and its implications for provenance change of the Chinese loess–red clay deposit(2010)

166 cited

→ Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics(2002)142 cited

Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China.(1994)

Studies of safe maximal daily dietary selenium intake in a seleniferous area in China. I. Selenium intake and tissue selenium levels of the inhabitants.(1989)